A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control
Scott B. Widenmaier(University of British Columbia), Christopher H.S. McIntosh(University of British Columbia)
Cited by 100
Related Papers
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression
|Journal of Biological Chemistry|2005|240
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
|Journal of Biological Chemistry|2007|208
GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene
|Journal of Lipid Research|2010|127
Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes
|Journal of Biological Chemistry|2007|115